Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 22, 2016
Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non-Small Cell Lung Cancer: A Phase I Dose Escalation Study
Jean-Louis Pujol, Tommaso De Pas, Achim Rittmeyer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 8, 2020
Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial
Elisabeth Quoix, Clarisse Audigier-Valette, Armelle Lavolé, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 22, 2019
A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial
Jean-Louis Pujol, Laurent Greillier, Clarisse Audigier-Valette, et al.
European Radiology
|
March 7, 2025
Multicenter external validation of a novel aggregated technique for percutaneous CT guided lung biopsy for multiple samplings: the ExtraPEARL study
Marco Calandri, Jacopo Brino, Steven Yevich, et al.
The Journal of Clinical Investigation
|
November 1, 2019
Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma
Emilie Bousquet Mur, Sara Bernardo, Laura Papon, et al.
Bulletin Du Cancer
|
November 21, 2002
[2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer]
Jeanne-Marie Bréchot, Thierry Molina, Serge Theobald, et al.
EMBO Molecular Medicine
|
January 16, 2026
NOTCH1 intracellular domain stabilization by MDM2 plays a major role in NSCLC response to platinum
Sara Bernardo, Lisa Brunet, Quentin Dominique Thomas, et al.
The Lancet. Oncology
|
May 2, 2016
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
Johan F Vansteenkiste, Byoung Chul Cho, Tonu Vanakesa, et al.
Lancet (London, England)
|
January 19, 2016
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
Fabrice Barlesi, Julien Mazieres, Jean-Philippe Merlio, et al.
The New England Journal of Medicine
|
May 15, 2024
Perioperative Nivolumab in Resectable Lung Cancer
Tina Cascone, Mark M Awad, Jonathan D Spicer, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 22, 2016
Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non-Small Cell Lung Cancer: A Phase I Dose Escalation Study
Jean-Louis Pujol, Tommaso De Pas, Achim Rittmeyer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 8, 2020
Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial
Elisabeth Quoix, Clarisse Audigier-Valette, Armelle Lavolé, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 22, 2019
A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial
Jean-Louis Pujol, Laurent Greillier, Clarisse Audigier-Valette, et al.
European Radiology
|
March 7, 2025
Multicenter external validation of a novel aggregated technique for percutaneous CT guided lung biopsy for multiple samplings: the ExtraPEARL study
Marco Calandri, Jacopo Brino, Steven Yevich, et al.
The Journal of Clinical Investigation
|
November 1, 2019
Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma
Emilie Bousquet Mur, Sara Bernardo, Laura Papon, et al.
Bulletin Du Cancer
|
November 21, 2002
[2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer]
Jeanne-Marie Bréchot, Thierry Molina, Serge Theobald, et al.
EMBO Molecular Medicine
|
January 16, 2026
NOTCH1 intracellular domain stabilization by MDM2 plays a major role in NSCLC response to platinum
Sara Bernardo, Lisa Brunet, Quentin Dominique Thomas, et al.
The Lancet. Oncology
|
May 2, 2016
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
Johan F Vansteenkiste, Byoung Chul Cho, Tonu Vanakesa, et al.
Lancet (London, England)
|
January 19, 2016
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
Fabrice Barlesi, Julien Mazieres, Jean-Philippe Merlio, et al.
The New England Journal of Medicine
|
May 15, 2024
Perioperative Nivolumab in Resectable Lung Cancer
Tina Cascone, Mark M Awad, Jonathan D Spicer, et al.
Page
of 10